Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

APOA5 variant Ser19Trp influences a decrease of the total cholesterol in a male 8 year cohort.

J A Hubacek1, Z Skodová, V Adámková

  • 1Institute for Clinical and Experimental Medicine, Prague, Czech Republic. jaroslav.hubacek@medicon.cz

Clinical Biochemistry
|January 3, 2006
PubMed
Summary

Genetic factors influence how diet affects cholesterol. The Ser19 > Trp variant of apolipoprotein A5 (APOA5) significantly impacts cholesterol reduction in response to dietary changes, highlighting personalized nutrition potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Effects of Early and Postponed Statin Treatment After Ovariectomy in Prediabetic Rat.

Physiological research·2026
Same author

Soluble endoglin reflects endothelial dysfunction in myocardial infarction patients: a retrospective observational study.

International journal of medical sciences·2025
Same author

PNPLA3 I148M variant is the main driver of weight gain after hepatitis C cure.

Scientific reports·2025
Same author

SARS-CoV-2 viral load is linked to remdesivir efficacy in severe Covid-19 admitted to intensive care.

Scientific reports·2024
Same author

The most common mistakes in intensive care - antibiotics.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2024
Same author

ABCA3 and LZTFL1 Polymorphisms and Risk of COVID-19 in the Czech Population.

Physiological research·2023

Area of Science:

  • Genetics
  • Nutritional Science
  • Cardiovascular Health

Background:

  • Dietary composition significantly impacts plasma lipid levels.
  • Understanding the genetic determinants of lipid response to diet is crucial for personalized health strategies.
  • Apolipoprotein A5 (APOA5) is a key regulator of triglyceride metabolism and is implicated in lipid disorders.

Purpose of the Study:

  • To investigate whether genetic variations in the apolipoprotein A5 (APOA5) gene influence the relationship between dietary composition and plasma lipid levels.
  • To evaluate the impact of specific APOA5 variants (T-1131 > C, Ser19 > Trp, Val153 > Met) on changes in plasma lipid concentrations over time in response to dietary modifications.

Main Methods:

  • A longitudinal study involving 117 males with significant dietary changes and a decrease in total cholesterol over an 8-year period.

Related Experiment Videos

  • Genotyping for common APOA5 variants (T-1131 > C, Ser19 > Trp, Val153 > Met).
  • Analysis of plasma lipid concentrations (including total cholesterol) at baseline and follow-up in relation to APOA5 genotypes.
  • Main Results:

    • The APOA5 T-1131 > C and Val153 > Met variants did not show a significant influence on lipid level changes.
    • Individuals with the Ser19 > Trp variant (Trp19 carriers) exhibited a greater than 20% decrease in plasma cholesterol, while Ser/Ser19 homozygotes showed a more modest 8% reduction.
    • The differential response in cholesterol reduction between Ser/Ser19 homozygotes and Trp19 carriers was statistically significant (P < 0.005).

    Conclusions:

    • The Ser19 > Trp variant within the APOA5 gene plays a significant role in modulating an individual's response to dietary interventions.
    • This finding suggests that genetic predisposition, specifically the APOA5 Ser19 > Trp variant, influences sensitivity to dietary composition.
    • Personalized dietary recommendations may be enhanced by considering APOA5 genetic status for optimizing lipid management.